These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 28250)

  • 21. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced apomorphine sensitivity and increased binding of dopamine D2 receptors in nucleus accumbens in prepubertal rats after neonatal blockade of the dopamine D3 receptors by (+)-S14297.
    Flores-Tochihuitl J; Vargas G; Morales-Medina JC; Rivera G; De La Cruz F; Zamudio S; Flores G
    Synapse; 2008 Jan; 62(1):40-9. PubMed ID: 17957737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scopolamine-induced hypermotility in rats is mediated via a dopaminergic system.
    Fink H; Morgenstern R
    Acta Biol Med Ger; 1980; 39(8-9):903-10. PubMed ID: 7282220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Centrally acting emetics. 10. Rigid dopamine congeners derived from octahydrobenzo[f]quinoline.
    Cannon JG; Hatheway GJ
    J Med Chem; 1976 Aug; 19(8):987-93. PubMed ID: 184283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity relationships for apomorphine congeners. Conformational energies vs. biological activities.
    Pettersson I; Liljefors T
    J Comput Aided Mol Des; 1987 Jul; 1(2):143-52. PubMed ID: 3504213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conformational analysis of dopamine by the INDO molecular orbital method.
    Grol CJ; Rollema H
    J Pharm Pharmacol; 1977 Mar; 29(3):153-6. PubMed ID: 15079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformationally restricted dopamine congeners--a molecular mechanics-based study.
    Kocjan D; Hadzi D
    J Pharm Pharmacol; 1983 Dec; 35(12):780-5. PubMed ID: 6141239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of dopamine receptor subtypes by comparative structure-activity relationships: dopaminomimetic activities and solid state conformation of monohydroxy-1,2,3,4,4a,5,10,10a-octahydrobenz[g]quinolines and its implications for a rotamer-based dopamine receptor model.
    Seiler MP; Markstein R; Walkinshaw MD; Boelsterli JJ
    Mol Pharmacol; 1989 May; 35(5):643-51. PubMed ID: 2566903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine D1 receptors of the calf parathyroid gland: identification and characterization.
    Niznik HB; Fogel EL; Chen CJ; Congo D; Brown EM; Seeman P
    Mol Pharmacol; 1988 Jul; 34(1):29-36. PubMed ID: 2839763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
    Seiler MP; Markstein R
    Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
    Leff SE; Creese I
    Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steric aspects of dopaminergic drugs.
    Miller DD
    Fed Proc; 1978 Aug; 37(10):2392-5. PubMed ID: 28250
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.